These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2350445)

  • 1. Antibodies to a putative HIV gp41 immunosuppressive peptide, pHIVIS (583-599), do not correlate significantly with outcome in HIV infection.
    Cheingsong-Popov R; Panagiotidi C; Caun K; Klasse PJ; Pipkorn R; Blomberg J; Weber J
    AIDS; 1990 Mar; 4(3):251-3. PubMed ID: 2350445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
    Klasse PJ; Pipkorn R; Blomberg J
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
    Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
    AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein.
    Ugen KE; Srikantan V; Goedert JJ; Nelson RP; Williams WV; Weiner DB
    J Infect Dis; 1997 Jan; 175(1):63-9. PubMed ID: 8985197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against human IFN-alpha and -beta recognized the immunosuppressive domain of HIV-1 gp41 and inhibit gp41-binding to the putative cellular receptor protein p45.
    Chen YH; Wu W; Yang J; Sui SF; Sun J; Dierich MP
    Immunol Lett; 1999 Aug; 69(2):253-7. PubMed ID: 10482360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibodies against the 15 amino acid sequence 599-613 of HIV-1 glycoprotein 41 in subjects at risk of HIV infection].
    Nardi G; Zanchetta N; Maiolani M; Berlusconi A; Salvaggio L
    Boll Ist Sieroter Milan; 1989; 68(3):277-83. PubMed ID: 2491437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR; Strick N; Lee ES
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential IgG subclass responses to epitopes in transmembrane protein of HIV-1.
    Klasse PJ; Blomberg J; Pipkorn R
    Viral Immunol; 1990; 3(2):89-98. PubMed ID: 1694431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of immune suppression by a synthetic HIV gp41 peptide.
    Wang H; Nishanian P; Fahey JL
    Cell Immunol; 1995 Apr; 161(2):236-43. PubMed ID: 7697734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1.
    Ugen KE; Goedert JJ; Boyer J; Refaeli Y; Frank I; Williams WV; Willoughby A; Landesman S; Mendez H; Rubinstein A
    J Clin Invest; 1992 Jun; 89(6):1923-30. PubMed ID: 1601999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for epitope-specific antibody responses to the human immunodeficiency virus (HIV-1) envelope glycoproteins signifying resistance to disease development.
    Neurath AR; Strick N; Taylor P; Rubinstein P; Stevens CE
    AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1183-92. PubMed ID: 1701315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Antibody Responses to a Peptide Antigen gp120-C5
    Sørensen B; Sommerfelt MA; Stjernholm G; Smith PL; Ökvist M; Hovden AO; Hoddevik G; Redfield R; Ustina V; Jelmert Ø; Zeldis J; Dalgleish A
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):558-566. PubMed ID: 28051320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of autologous neutralizing antibodies in the cerebrospinal fluid of HIV-1 infected individuals.
    von Gegerfelt A; Chiodi F; Keys B; Norkrans G; Hagberg L; Fenyö EM; Broliden K
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1133-8. PubMed ID: 1503825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges.
    Bomsel M; Tudor D; Drillet AS; Alfsen A; Ganor Y; Roger MG; Mouz N; Amacker M; Chalifour A; Diomede L; Devillier G; Cong Z; Wei Q; Gao H; Qin C; Yang GB; Zurbriggen R; Lopalco L; Fleury S
    Immunity; 2011 Feb; 34(2):269-80. PubMed ID: 21315623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of anti-gp41 core structure antibodies, which compete with sera of HIV-1-infected patients.
    Usami O; Xiao P; Ling H; Liu Y; Nakasone T; Hattori T
    Microbes Infect; 2005 Apr; 7(4):650-7. PubMed ID: 15823513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.
    Ringel O; Müller K; Koch J; Brill B; Wolf T; Stephan C; Vieillard V; Debré P; Dietrich U
    AIDS Res Hum Retroviruses; 2018 Apr; 34(4):365-374. PubMed ID: 29262692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
    Denner J; Norley S; Kurth R
    AIDS; 1994 Aug; 8(8):1063-72. PubMed ID: 7986401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
    Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
    Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoire.
    de Haard JJ; Kazemier B; Oudshoorn P; Boender P; van Gemen B; Koolen MJ; van der Groen G; Hoogenboom HR; Arends JW
    J Gen Virol; 1998 Dec; 79 ( Pt 12)():2883-94. PubMed ID: 9880001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.